Physician profile
Keith S Moore
NPI 1154302784
$1,816.79
in general payments reported to CMS, 2019-2025
14 companies · $78.10 in 2025
The $78.10 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $254 · 2021: $36.86 · 2022: $296 · 2023: $606 · 2024: $142 · 2025: $78.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $922.38 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic, INC. | $338.04 | 2022-2023 | Venaseal |
| Impedimed, INC. | $146.35 | 2023 | |
| Medtronic Vascular, INC. | $129.47 | 2019 | |
| Organogenesis INC. | $79.70 | 2022-2023 | Puraply |
| Cashflow Solutions, LLC | $43.66 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Kerecis Limited | $27.47 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Evoke Pharma, INC. | $24.87 | 2021 | |
| Progenacare Global, LLC | $21.70 | 2023 | |
| Urgo Medical North America, LLC | $20.74 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Takeda Pharmaceuticals U.S.A., INC. | $20.18 | 2023 | Entyvio |
| Normatec Industries, LP | $20.02 | 2019 | |
| Allergan, INC. | $11.24 | 2019 | |
| Boston Scientific Corporation | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.